Sales rise 35.67% to Rs 26.28 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 6.85 crore in the quarter ended March 2016 as against net loss of Rs 22.77 crore during the previous quarter ended March 2015. Sales rose 35.67% to Rs 26.28 crore in the quarter ended March 2016 as against Rs 19.37 crore during the previous quarter ended March 2015.For the full year,net loss reported to Rs 12.18 crore in the year ended March 2016 as against net profit of Rs 6.11 crore during the previous year ended March 2015. Sales declined 15.87% to Rs 85.32 crore in the year ended March 2016 as against Rs 101.41 crore during the previous year ended March 2015.
ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales26.2819.37 36 85.32101.41 -16 OPM %-9.47-121.12 -3.3125.00 - PBDT-5.89-25.74 77 -8.4114.01 PL PBT-7.66-26.10 71 -12.528.77 PL NP-6.85-22.77 70 -12.186.11 PL
Powered by Capital Market - Live News
